The novel 11b-hydroxysteroid dehydrogenase type 1 (11b -HSD1) inhibitors known as sterenin A, B, C and D were found in a solid-state culture of the producing basidiomycetes identified as Stereum sp. SANK 21205. Purification of the 50% aq Me 2 CO extract of the culture was performed by EtOAc extraction, reversed phase opencolumn chromatography and successive ODS HPLC preparation. These compounds, whose structures were determined by several spectroscopic methods, were found to be novel isoindolinone alkaloids which exhibited potent selective inhibitory activities against 11b-HSD1.
Introduction
Metabolic syndrome is a general term referring to the accumulation of associated disorders characterized by insulin resistance, obesity, dyslipidemia and hypertension, which are major risk factors for cardiovascular diseases and atherosclerosis. Among the many factors that play a role in this syndrome, glucocorticoids have received considerable attention. Excess glucocorticoid levels cause glucose intolerance and insulin resistance, clinically indicating Cushing's syndrome [1, 2] , which closely resembles metabolic syndrome. Accumulated evidence suggests that 11b-hydroxysteroid dehydrogenase (11b-HSD), an enzyme responsible for producing glucocorticoids in tissues, is upregulated in obesity subjects, including humans [3ϳ5] . Targeted disruption of 11b -HSD in mice exhibits a protective glycemic, lipid and lipoprotein profile. As glucocorticoids oppose the insulin effect, several studies with mice lacking [6] or overexpressing [7] 11b -HSD1 reported that 11b-HSD1 plays an important role in Type 2 diabetes and metabolic syndrome. Thus, an 11b -HSD1 inhibitor is expected to be a promising target in the treatment of metabolic syndrome.
In the course of screening natural products with 11b -HSD1 inhibitory activity, one basidiomycete was found to be the active compound producer designated Stereum sp. SANK 21205. Here, we describe the taxonomy of the producing organism, and the fermentation, isolation, structural elucidation and biological activities of sterenin A, B, C and D (Fig. 1) , which are novel 11b -HSD1 inhibitors.
Materials and Methods

General
The 1 H-and 13 C-NMR spectra were recorded at 298K on an AVANCE 500 spectrometer equipped with a cryogenic probe (Bruker BioSpin) operating at 500 MHz and 125 MHz, respectively. The samples for NMR characterization were dissolved in CD 3 OD. The optical rotation and IR spectra were measured with a DIP-370 (JASCO) and a VALOR-III (JASCO), respectively. The mass spectra and high-resolution mass spectra were measured with a JMS700QV Mstation (JEOL). HPLC analysis was carried out with an HP1100 system (Agilent).
Preparation of 11b b-HSD1-expressing Microsomes
Human and mouse 11b -HSD1 cDNA were amplified by RT-PCR and sub-cloned into a pCIneo (Promega) expression vector. Expression plasmid was transfected into Hek293 cells using Lipofectamine plus reagent (Invitrogen). At 48 hours post-transfection, the cells were harvested, suspended in Hepes buffer (20 mM Hepes (pH 7.4), 1.0 mM EDTA, 2.0 mM MgCl 2 and protease inhibitor cocktail (Roche)) and disrupted by N 2 cavitation at 4.1 MPa. The cell homogenates were centrifuged for 10 minutes at 1,000 g and the pellets were discarded. The supernatants were re-centrifuged at 105,000 g for 30 minutes. The pellets were re-suspended in reaction buffer (50 mM Tris (pH7.4), 10% glycerol).
11b b-HSD1 Reductase Assay
The microsomes were incubated in reaction buffer for 3 hours at room temperature (26°C) with an NADPH generation system (0.8 mM NADPH, 6.0 mM glucose-6-phosphate, 0.35 U/ml glucose-6-phosphate dehydrogenase, 3.0 mM MgCl 2 ), respective concentrations of sterenins and 160 nM of substrate (human: cortisone, mouse: 11-dehydrocorticosterone). The reaction was stopped by adding 50 mM of carbenoxolone and the product (human: cortisol, mouse: corticosterone) concentration was determined using HTRF Cortisol Assay Reagents (Cisbio).
Preparation of 11b b-HSD2-expressing Microsomes
Human 11b -HSD2 cDNA was amplified by RT-PCR and sub-cloned into pFastBac vector (Invitrogen). Recombinant baculovirus was generated using a Bac-to-Bac Baculovirus Expression System (Invitrogen). Sf9 insect cells infected with baculovirus were harvested 48 hours after infection and microsomes were prepared in the same way as described above. minutes at room temperature (26°C) with 43 mM of NAD, respective concentrations of sterenins and 160 nM of cortisol. The reaction was terminated by the addition of 50 mM of carbenoxolone and the cortisol concentration was determined using HTRF Cortisol Assay Reagents.
Results
Taxonomy of the Producing Organism
The producing strain, SANK 21205, was isolated from the spore print of fresh basidiocarps collected in Gunma Prefecture, Japan. As this basidiomycete could not be characterized by its cultural features, the observation of dried basidiocarps was needed for identification. The morphological characteristics of the dried basidiocarps are shown in Fig. 2 .
The basidiocarps were resupinate to effused-reflexed. The pilei were up to 5.0 mm in width, up to 0.4 mm in thickness, dimidiate to flabellate, and were usually coalescent and tough. The upper surface was hirsute and grayish white. The margin of the pilei was thin and acute. The hymenial surface was smooth to slightly tuberculate and pale orange. Cutis was present, which was brown and up to 25 mm in thickness.
The basidiospores were 8.0ϳ12.0ϫ3ϳ4.0 m m, cylindrical, often slightly curved, thin-walled, smooth, and amyloid. The basidia were 40ϳ50ϫ5.0ϳ6.0 mm, narrowly clavate, with 4 sterigamata, which were up to 4.0 m m in length. The pseudocystidia were 4.5ϳ6.0 m m in width, cylindrical, thick-walled at the base (up to 2.0 m m), thinwalled at the apex, often with small points. The hyphal system was monomitic. The hyphae were 2.0ϳ6.0 m m in width, thin-walled to thick-walled, and without clamp connections. Acanthohyphidia or pseudoacanthohyphidia were not observed.
The above characteristics of the basidiocarps corresponded with the description of the genus Stereum [8] . Hence, the strain was identified as Stereum sp. This strain has been deposited at the National Institute of Advanced Industrial Science and Technology, Japan, as Stereum sp. SANK 21205 under the accession number FERM BP-10465.
Fermentation
The growth of Stereum sp. SANK 21205 on an agar slant (1 cm 3 ) was homogenized with sterile water (3.0 ml). Then the whole amount of the homogenate was transferred into a 100-ml Erlenmeyer flask containing 30 ml of a sterilized liquid seed medium composed of glucose 0.4%, malt extract 1.0%, yeast extract 0.4%, agar 0.3% and Disfoam CB-442 (Nippon Yushi Co.) 0.005%. The flask was incubated at 23°C for 7 days on a rotary shaker at 210 rpm. The seed culture (30 ml) was transferred into a 500-ml AGRIFLEX bag (Fujimori Kogyo Co., Ltd.) containing a sterilized production medium which was composed of brown rice 90 g, NaNO 3 0.05 g, KH 2 PO 4 0.05 g, MgSO 4 · 7H 2 O 0.05 g and distilled water 100 ml. The fermentation was carried out at 23°C for 14 days by stationary cultivation.
Isolation
An equal volume of Me 2 CO was added to the harvested culture (3.0 liters, 60 bags), which was left stirring for 30 minutes. And then, the extract was filtered by the aid of diatomaceous earth (Celite Co., 150 g). The yielded filtrate was adjusted to pH 3.0 with 6 M HCl and the active substance was extracted by EtOAc (3.5 liters). The extract was washed with saturated brine (2.0 liters) and dried over anhydrous Na 2 SO 4 for 1 hour. The filtered extract was concentrated in vacuo to dryness to obtain oily material (13 g ). The material was dissolved into MeOH (50 ml) and reversed phase silica gel powder (Cosmosil 140C 18 -OPN, Nakalai Tesque, 60 g) was added to the solution by stirring. After the removal of the MeOH by evaporation, 0.3% triethylamine-phosphate buffer (pH 3.0, 400 ml) was added to the material adsorbed powder to make slurry. The obtained slurry was layered onto the Cosmosil 140C 18 -OPN column (600 ml) equilibrated with 10% CH 3 CN in H 2 O containing 0.3% triethylamine-phosphate buffer (pH 3.0). desalted by extraction with EtOAc (700 ml). The solvent layer was washed with saturated brine (600 ml) and dried over anhydrous Na 2 SO 4 for 1 hour. Filtered extract was concentrated in vacuo to dryness to yield crude material (335 mg). Part of it (130 mg) was dissolved into MeOH (2.0 ml) and a 200 ml portion was applied to a preparative HPLC (column; Capcell Pak C18 UG120, 20ϫ250 mm, mobile phase; CH 3 CN -H 2 O (37 : 63) containing 0.05% HCOOH, flow rate; 10 ml/minute, detection; UV at 210 nm). Preparations performed ten times obtained four isolated fractions which contained active compounds. Each fraction was concentrated in vacuo to remove the CH 3 CN and, after freeze drying, they yielded pure sterenin A (24 mg), B (25 mg), C (11 mg) and D (10 mg) as white 132 powders.
Physico-chemical Properties
The physico-chemical properties of sterenin A, B, C and D are summarized in Table 2 . These NMR spectral data suggest that their structures are closely related to each other. The connectivity of these two partial structures was clarified by a deuterium shift experiment using samples in CD 3 OD and in CD 3 OH in a coaxial tube. The shift values in Hz (Dd CH 3 OH -CD 3 OD ) are shown in Fig. 4 . All the carbon signals within the two-bond distance from the applicable oxygen atoms except for those around positions 6 and 7Љ exhibited deuterium shifts and the isoprenylisoindolinone and o-orsellinic acid were thereby linked via an ester bond at C-6 and C-7Љ. Thus, the structure of sterenin A was elucidated as shown in Fig. 1. Sterenin B, C and D According to the NMR analysis of sterenin B, C and D shown in Fig. 3 , it was concluded that they were different analogues based on variations of the N-linked side chain in sterenin A (Fig. 1) .
Structure Elucidations
Biological Activities
Sterenin homologues inhibited human 11b -HSD1 activity in a dose-dependent manner (Fig. 5) . To analyse the 11b-HSD1 inhibition mechanism of sterenin A, we performed a kinetic analysis. The Lineweaver-Burk plots revealed that sterenin A behaved as a competitive inhibitor (Fig. 6) . The Ki value of sterenin A was calculated to be 68 nM. The inhibitory effects of all the homologues were isoform specific, as they did not inhibit human 11b -HSD2 (Table  3) .
Discussion
In the present study, we report the discovery of novel 11b-HSD1 inhibitors named sterenin A, B, C and D from a solid-state culture of producing basidiomycetes identified as Stereum sp. SANK 21205. Among various kinds of reported isoindolinone type alkaloids, 2,5-dimethyl-6-methoxy-4,7-dihydroisoindole-4,7-dione [9] , described as the first naturally-occurring isoindole with antibacterial activity from sponge, stachybotrins [10] with antibacterial and fungicidal activities, staplabin [11] and a series of compounds named SMTPs [12ϳ16] as tissue plasminogen modulators, are listed as related compounds. During the screening process, we isolated stachybotrin homologues, but their inhibitory activities against human 11b -HSD1 were approximately ten times weaker than those of sterenin A and C (data not shown). To the best of our knowledge, this is the first report of natural products which possess potent 11b-HSD1 inhibitory activities.
From the standpoint of the producing organism, there is literature that comments on Stereum hirsutum, which belongs to the same genus as the strain SANK 21205, and which produces a related compound named MS-3 [17ϳ19]. Although this compound was reported to be a glyoxalase I inhibitor and a growth inhibitor of sarcoma cells in vitro, MS-3 would be one of the precursors of sterenin homologues in terms of biosynthesis.
As described above, sterenin derivatives are potent competitive inhibitors with strict selectivity against 11b -HSD1 versus 11b -HSD2. It is intriguing to note that sterenin A and C possess ten to thirty times stronger activities than those of sterenin B and D. Among these homologues, sterenin B exhibited the weakest inhibitory activity. In view of the contribution of its stereochemistry to the activity, we did not determine the configuration of sterenin B. It is possible to say that the size and/or charge of the N-linked side chain on the isoindolinone skeleton play a critical role in the inhibitory activity. Further structure-activity relationship (SAR) studies will be needed to determine the usefulness of sterenins against Type 2 diabetes and metabolic syndrome. The total synthesis of sterenins and the X-ray crystallographic analysis of their enzyme complexes will be separately reported elsewhere. 
